Effect of subcutaneous insulin detemir on glucose flux, lipolysis and electroencephalography in type 1 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 11, 2015-11 ,pp. : 1100-1103

John Wiley & Sons Inc

Access to resources Recommend Favorite

Glucose‐lowering effect and glycaemic variability of insulin glargine, insulin detemir and insulin lispro protamine in people with type 1 diabetes

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 17, Iss. 6, 2015-06 ,pp. : 554-559

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evidence for abnormal glucose uptake or metabolism in thalamus during acute hyperglycaemia in type 1 diabetes—a ¹H MRS study

By Heikkilä Outi   Lundbom Nina   Timonen Marjut   Groop Per-Henrik   Heikkinen Sami   Mäkimattila Sari  

Metabolic Brain Disease, Vol. 25, Iss. 2, 2010-06 ,pp. : 227-234

Springer Publishing Company

Access to resources Recommend Favorite

The outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis

By Currie Craig J.   Poole Chris D.   Tetlow Tony   Holmes Paul   McEwan Phil  

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-02 ,pp. : 33-39

Informa Healthcare

Access to resources Recommend Favorite

The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis

By Poole Chris D.   Tetlow Tony   McEwan Phil   Holmes Paul   Currie Craig J.  

Current Medical Research and Opinion, Vol. 23, Iss. 1, 2007-02 ,pp. : 41-48

Informa Healthcare

Access to resources Recommend Favorite